€4.37
0.81%
Madrid, Oct 03, 05:35 pm CET
ISIN
ES0134950F36
Symbol
FAE

Faes Farma SAReg Target price 2025 - Analyst rating & recommendation

Faes Farma SAReg Classifications & Recommendation:

Buy
67%
Hold
33%

Faes Farma SAReg Price Target

Target Price €4.90
Price €4.37
Potential
Number of Estimates 6
6 Analysts have issued a price target Faes Farma SAReg 2026 . The average Faes Farma SAReg target price is €4.90. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 9 analysts: 6 Analysts recommend Faes Farma SAReg to buy, 3 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Faes Farma SAReg stock has an average upside potential 2026 of . Most analysts recommend the Faes Farma SAReg stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2030

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Revenue Million € 493.65 561.43
9.42% 13.73%
EBITDA Margin 26.10% 22.16%
3.66% 15.10%
Net Margin 22.56% 14.98%
10.75% 33.59%

6 Analysts have issued a sales forecast Faes Farma SAReg 2025 . The average Faes Farma SAReg sales estimate is

€561m
Unlock
. This is
6.20% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
€617m 16.79%
Unlock
, the lowest is
€519m 1.75%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 €494m 9.42%
2025
€561m 13.73%
Unlock
2026
€636m 13.23%
Unlock
2027
€697m 9.58%
Unlock
2028
€704m 1.06%
Unlock
2029
€726m 3.14%
Unlock
2030
€780m 7.38%
Unlock

6 Analysts have issued an Faes Farma SAReg EBITDA forecast 2025. The average Faes Farma SAReg EBITDA estimate is

€124m
Unlock
. This is
0.73% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
€133m 7.95%
Unlock
, the lowest is
€117m 5.59%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 €129m 5.41%
2025
€124m 3.43%
Unlock
2026
€155m 24.28%
Unlock
2027
€175m 13.42%
Unlock
2028
€171m 2.36%
Unlock
2029
€181m 5.58%
Unlock
2030
€197m 8.95%
Unlock

EBITDA Margin

2024 26.10% 3.66%
2025
22.16% 15.10%
Unlock
2026
24.33% 9.79%
Unlock
2027
25.18% 3.49%
Unlock
2028
24.33% 3.38%
Unlock
2029
24.90% 2.34%
Unlock
2030
25.27% 1.49%
Unlock

6 Faes Farma SAReg Analysts have issued a net profit forecast 2025. The average Faes Farma SAReg net profit estimate is

€84.1m
Unlock
. This is
20.17% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
€91.5m 13.13%
Unlock
, the lowest is
€76.3m 27.61%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 €111m 21.18%
2025
€84.1m 24.49%
Unlock
2026
€108m 28.04%
Unlock
2027
€122m 12.90%
Unlock
2028
€130m 7.07%
Unlock
2029
€122m 6.59%
Unlock
2030
€134m 10.27%
Unlock

Net Margin

2024 22.56% 10.75%
2025
14.98% 33.59%
Unlock
2026
16.94% 13.08%
Unlock
2027
17.45% 3.01%
Unlock
2028
18.49% 5.96%
Unlock
2029
16.74% 9.46%
Unlock
2030
17.19% 2.69%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2030

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Earnings Per Share 0.36 0.27
20.00% 25.00%
P/E 16.17
EV/Sales 2.47

6 Analysts have issued a Faes Farma SAReg forecast for earnings per share. The average Faes Farma SAReg EPS is

€0.27
Unlock
. This is
20.59% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
€0.29 14.71%
Unlock
, the lowest is
€0.25 26.47%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 €0.36 20.00%
2025
€0.27 25.00%
Unlock
2026
€0.35 29.63%
Unlock
2027
€0.39 11.43%
Unlock
2028
€0.42 7.69%
Unlock
2029
€0.39 7.14%
Unlock
2030
€0.43 10.26%
Unlock

P/E ratio

Current 12.85 7.25%
2025
16.17 25.81%
Unlock
2026
12.63 21.89%
Unlock
2027
11.19 11.40%
Unlock
2028
10.45 6.61%
Unlock
2029
11.19 7.08%
Unlock
2030
10.15 9.29%
Unlock

Based on analysts' sales estimates for 2025, the Faes Farma SAReg stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.62 8.26%
2025
2.47 5.88%
Unlock
2026
2.18 11.68%
Unlock
2027
1.99 8.74%
Unlock
2028
1.97 1.05%
Unlock
2029
1.91 3.04%
Unlock
2030
1.78 6.87%
Unlock

P/S ratio

Current 2.56 3.53%
2025
2.41 5.84%
Unlock
2026
2.13 11.68%
Unlock
2027
1.94 8.74%
Unlock
2028
1.92 1.05%
Unlock
2029
1.86 3.04%
Unlock
2030
1.73 6.87%
Unlock

Current Faes Farma SAReg Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
ODDO BHF
Locked
Locked
Locked Jul 25 2025
BANCO SANTANDER
Locked
Locked
Locked Jul 23 2025
BANCO SANTANDER
Locked
Locked
Locked Jul 10 2025
BANCO SANTANDER
Locked
Locked
Locked Jul 09 2025
CAIXABANK BPI
Locked
Locked
Locked Jun 30 2025
CAIXABANK BPI
Locked
Locked
Locked Jun 29 2025
ODDO BHF
Locked
Locked
Locked May 30 2025
Analyst Rating Date
Locked
ODDO BHF:
Locked
Locked
Jul 25 2025
Locked
BANCO SANTANDER:
Locked
Locked
Jul 23 2025
Locked
BANCO SANTANDER:
Locked
Locked
Jul 10 2025
Locked
BANCO SANTANDER:
Locked
Locked
Jul 09 2025
Locked
CAIXABANK BPI:
Locked
Locked
Jun 30 2025
Locked
CAIXABANK BPI:
Locked
Locked
Jun 29 2025
Locked
ODDO BHF:
Locked
Locked
May 30 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today